Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany
The spread of Gram-negative bacteria with plasmid-borne extended-spectrum β-lactamases (ESBLs) has become a worldwide problem. This study analysed a total of 366 ESBL-producing Enterobacteriaceae strains isolated from non-selected patient specimens at the university hospital of Tübingen in the period January 2003 to December 2007. Although the overall ESBL rate was comparatively low (1.6 %), the percentages of ESBL-producing Enterobacter spp. and Escherichia coli increased from 0.8 and 0.5 %, respectively, in 2003 to 4.6 and 3.8 % in 2007. In particular, the emergence was observed of one carbapenem-resistant ESBL-producing E. coli isolate and five carbapenem-non-susceptible ESBL-positive Klebsiella pneumoniae isolates, in two of which carbapenem resistance development was documented in vivo under a meropenem-containing antibiotic regime. The possible underlying mechanism for this carbapenem resistance in three of the K. pneumoniae isolates was loss of the Klebsiella porin channel protein OmpK36 as shown by PCR analysis. The remaining two K. pneumoniae isolates exhibited increased expression of a tripartite AcrAB–TolC efflux pump as demonstrated by SDS-PAGE and mass spectrometry analysis of bacterial outer-membrane extracts, which, in addition to other unknown mechanisms, may contribute towards increasing the carbapenem MIC values further. Carbapenem-non-susceptible ESBL isolates may pose a new problem in the future due to possible outbreak situations and limited antibiotic treatment options. Therefore, a systematic exploration of intestinal colonization with ESBL isolates should be reconsidered, at least for haemato-oncological departments from where four of the five carbapenem-non-susceptible ESBL isolates originated.
AndersonK. F.,
LonswayD. R.,
RasheedJ. K.,
BiddleJ.,
JensenB.,
McDougalL. K.,
CareyR. B.,
ThompsonA.,
StockerS.other authors2007; Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae
. J Clin Microbiol 45:2723–2725[CrossRef]
BarjaktarovicZ.,
NordheimA.,
LamkemeyerT.,
FladererC.,
MadlungJ.,
HamppR.2007; Time-course of changes in amounts of specific proteins upon exposure to hyper-g, 2-D clinorotation, and 3-D random positioning of Arabidopsis cell cultures. J Exp Bot 58:4357–4363[CrossRef]
BornetC.,
CholletR.,
MalleaM.,
ChevalierJ.,
Davin-RegliA.,
PagesJ. M.,
BolletC.2003; Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes
. Biochem Biophys Res Commun 301:985–990[CrossRef]
BradfordP. A.,
UrbanC.,
MarianoN.,
ProjanS. J.,
RahalJ. J.,
BushK.1997; Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β -lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41:563–569
CaroffN.,
EspazeE.,
GautreauD.,
RichetH.,
ReynaudA.2000; Analysis of the effects of −42 and −32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J Antimicrob Chemother 45:783–788[CrossRef]
Castillo GarcíaF. J.,
Seral GarcíaC.,
Pardos De la GandaraM.,
Millán LouM. I.,
Pitart FerréC.2007; Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two non-outbreak periods. Eur J Clin Microbiol Infect Dis 26:77–78[CrossRef]
CrowleyB.,
BenediV. J.,
Domenech-SanchezA.2002; Expression of SHV-2 β -lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob Agents Chemother 46:3679–3682[CrossRef]
Fernandez-RecioJ.,
WalasF.,
FedericiL.,
VenkateshP. J.,
BavroV. N.,
MiguelR. N.,
MizuguchiK.,
LuisiB.2004; A model of a transmembrane drug-efflux pump from Gram-negative bacteria. FEBS Lett 578:5–9[CrossRef]
GrimmV.,
EzakiS.,
SusaM.,
KnabbeC.,
SchmidR. D.,
BachmannT. T.2004; Use of DNA microarrays for rapid genotyping of TEM beta-lactamases that confer resistance. J Clin Microbiol 42:3766–3774[CrossRef]
HasdemirU. O.,
ChevalierJ.,
NordmannP.,
PagesJ. M.2004; Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol 42:2701–2706[CrossRef]
Hernández-AllésS.,
BenedíV. J.,
Martínez-MartínezL.,
PascualA.,
AguilarA.,
TomásJ. M.,
AlbertíS.1999; Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob Agents Chemother 43:937–939
HuW. S.,
YaoS. M.,
FungC. P.,
HsiehY. P.,
LiuC. P.,
LinJ. F.2007; An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii
. Antimicrob Agents Chemother 51:3844–3852[CrossRef]
JacobyG. A.,
MillsD. M.,
ChowN.2004; Role of β -lactamases and porins in resistance to ertapenem and other β -lactams in Klebsiella pneumoniae
. Antimicrob Agents Chemother 48:3203–3206[CrossRef]
KaczmarekF. M.,
Dib-HajjF.,
ShangW.,
GootzT. D.2006; High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla ACT-1β -lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother 50:3396–3406[CrossRef]
LeeC. H.,
ChuC.,
LiuJ. W.,
ChenY. S.,
ChiuC. J.,
SuL. H.2007; Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of bla DHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 β -lactamases. J Antimicrob Chemother 60:410–413[CrossRef]
Martínez-MartínezL.,
Hernández-AllésS.,
AlbertíS.,
TomásJ. M.,
BenediV. J.,
JacobyG. A.1996; In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. Antimicrob Agents Chemother 40:342–348
Martínez-MartínezL.,
PascualA.,
Hernández-AllésS.,
Alvarez-DíazD.,
SuárezA. I.,
TranJ.,
BenedíV. J.,
JacobyG. A.1999; Roles of β -lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae
. Antimicrob Agents Chemother 43:1669–1673
MenaA.,
PlasenciaV.,
GarciaL.,
HidalgoO.,
AyestaránJ. I.,
AlbertiS.,
BorrellN.,
PérezJ. L.,
OliverA.2006; Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44:2831–2837[CrossRef]
MulveyM. R.,
BryceE.,
BoydD. A.,
Ofner-AgostiniM.,
LandA. M.,
SimorA. E.,
PatonS.2005; Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 49:358–365[CrossRef]
OsbornM. J.,
GanderJ. E.,
ParisiE.,
CarsonJ.1972; Mechanism of assembly of the outer membrane of Salmonella typhimurium . Isolation and characterization of cytoplasmic and outer membrane. J Biol Chem 247:3962–3972
OteoJ.,
NavarroC.,
CercenadoE.,
Delgado-IribarrenA.,
WilhelmiI.,
OrdenB.,
GarcíaC.,
MiguelañezS.,
Pérez-VázquezM.other authors2006; Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 44:2359–2366[CrossRef]
PatersonD. L.,
HujerK. M.,
HujerA. M.,
YeiserB.,
BonomoM. D.,
RiceL. B.,
BonomoR. A.2003; Extended-spectrum β -lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β -lactamases. Antimicrob Agents Chemother 47:3554–3560[CrossRef]
PerkinsD. N.,
PappinD. J.,
CreasyD. M.,
CottrellJ. S.1999; Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551–3567[CrossRef]
PrilipovA.,
PhaleP. S.,
Van GelderP.,
RosenbuschJ. P.,
KoebnikR.1998; Coupling site-directed mutagenesis with high-level expression: large scale production of mutant porins from E. coli
. FEMS Microbiol Lett 163:65–72[CrossRef]
SchäggerH.,
von JagowG.1987; Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368–379[CrossRef]
StruyveM.,
MoonsM.,
TommassenJ.1991; Carboxy-terminal phenylalanine is essential for the correct assembly of a bacterial outer membrane protein. J Mol Biol 218:141–148[CrossRef]
TonkicM.,
Goic-BarisicI.,
Punda-PolicV.2005; Prevalence and antimicrobial resistance of extended-spectrum β -lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia. Int Microbiol 8:119–124
ValverdeA.,
GrillF.,
CoqueT. M.,
PintadoV.,
BaqueroF.,
CantonR.,
CoboJ.2008; High rate of intestinal colonization with extended spectrum β -lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 46:2796–2799[CrossRef]
WalshT. R.,
BolmstromA.,
QwarnstromA.,
GalesA.2002; Evaluation of a new Etest for detecting metallo- β -lactamases in routine clinical testing. J Clin Microbiol 40:2755–2759[CrossRef]
WoodfordN.,
TiernoP. M.Jr,
YoungK.,
TysallL.,
PalepouM. F.,
WardE.,
PainterR. E.,
SuberD. F.,
ShunguD.other authors2004; Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β -lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 48:4793–4799[CrossRef]
Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany